Abbott has announced the international launch of its everolimus-eluting coronary stent system [Xience V].
Source: Inpharma, Volume 1, Number 1559, 2006-10-14 , pp. 23-23(1)
Publisher: Adis International
Keywords: Coronary-artery-restenosis, prevention; Coronary-stenting; Development-status; Drug-delivery-systems; Everolimus, therapeutic use; Product-launches; Research-and-development; Zotarolimus, therapeutic use
Document Type: Short communication
Publication date: 2006-01-01
- In this: publication
- By this: publisher
- In this Subject: Pharmacology

Shopping cart
Receive new issue alert
Get Permissions